Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effectt

Therapeutic indication

Contraindication

Target species

Withdrawal period

User safety

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Veterinary medicinal products

The veterinary summaries of product characteristics (SPC) contain information essential for their use about the properties of the veterinary medicines. The veterinary SPCs are targeted at veterinary surgeons and may therefore contain terminology which requires veterinary expertise. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: o


Summaries of Product Characteristics 1 - 21 of 21
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Oftaquix 5 mg_ml silmätipat,liuos SPC 2020-10-02

European Medicines Agency's website:
Oncept IL-2 - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Onsior - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Ophtaclin vet 10 mg-g silmävoide SPC 2022-09-09

PL

Resepti

Optimmune vet 2 mg-g silmävoide SPC 2023-09-12

PL

Resepti

Orbenin retard vet 500 mg intramammaarisuspensio SPC 2023-09-06

PL

Resepti

Orbeseal 2,6 g intramammaarisuspensio SPC 2023-05-04

PL

Resepti

Orimycin vet 200 mg-g jauhe SPC 2021-05-11

PL

Resepti

Oriprim vet jauhe SPC 2021-05-07

PL

Resepti

Osphos 51 mg-ml injektioneste, liuos SPC 2021-03-25

PL

Resepti

Osteopen vet 100 mg-ml injektioneste, liuos SPC 2021-06-17

European Medicines Agency's website:
Osurnia - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Otimectin vet 1 mg-ml korvageeli SPC 2013-11-04

PL

Resepti

Otisur vet 23,0 mg-ml + 5,0 mg-ml + 5500 IU-ml korvatipat, suspensio SPC 2023-01-10

PL

Resepti

Otomax vet korvatipat, suspensio SPC 2021-12-08

PL

Resepti

Ovareline 50 mikrog-ml injektioneste, liuos SPC 2019-07-16.docx

European Medicines Agency's website:
OvuGel - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Oxmax - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Oxybee - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Oxycontin Depot 5 mg, 10 mg, 20 mg, 40 mg, 80 mg depottabletti SPC 2020-09-04

European Medicines Agency's website:
Oxyglobin - EMA: EPAR PI
Finnish Swedish